期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
四边简支共固化复合材料阻尼结构的动力学性能研究(英文) 被引量:2
1
作者 王绍清 张俊玲 +1 位作者 翟彦春 梁森 《机床与液压》 北大核心 2018年第24期36-41,共6页
嵌入式共固化复合材料阻尼结构具有阻尼性能优良、抗老化、不脱落、耐疲劳等优点,在设施农业、机床制造业、航空航天、建筑等技术领域具有广阔的应用前景。应用模态应变能法研究了共固化复合材料阻尼结构各层的应变能,并计算了结构的一... 嵌入式共固化复合材料阻尼结构具有阻尼性能优良、抗老化、不脱落、耐疲劳等优点,在设施农业、机床制造业、航空航天、建筑等技术领域具有广阔的应用前景。应用模态应变能法研究了共固化复合材料阻尼结构各层的应变能,并计算了结构的一阶模态国有频率和损耗因子,得到了一阶固有频率和损耗因子随阻尼层厚度变化的规律。结果表明:当薄板总厚度不变时,增加阻尼层的厚度可以使一阶固有频率减小,模态损耗因子随着阻尼层厚度的增大而增大,阻尼层较厚时,一阶固有频率和模态损耗因子对阻尼层厚度的变化不再敏感;当复合材料层厚度不变时,一阶固有频率随着阻尼层厚度的增大而减小,增加阻尼层的厚度可以使损耗因子增大,阻尼层厚度较厚时,阻尼层厚度的变化对一阶固有频率和损耗因子的影响较小;当薄板总厚度不变,较复合材料层厚度不变,阻尼层较厚时对损耗因子的影响更小。 展开更多
关键词 复合材料 粘弹性材料 共固化 损耗因子
下载PDF
Efficacy of afatinib in a patient with rare EGFR(G724S/R776H)mutations and amplification in lung adenocarcinoma:A case report
2
作者 Shu-Yan He Qing-Feng Lin +3 位作者 Jie Chen Gui-Ping Yu jun-ling zhang Dong Shen 《World Journal of Clinical Cases》 SCIE 2021年第6期1329-1335,共7页
BACKGROUND The most common EGFR mutations are in-frame deletions in exon 19 and point mutations in exon 21.Cases with classical EGFR mutations show a good response to EGFR tyrosine kinase inhibitors(TKIs),the standard... BACKGROUND The most common EGFR mutations are in-frame deletions in exon 19 and point mutations in exon 21.Cases with classical EGFR mutations show a good response to EGFR tyrosine kinase inhibitors(TKIs),the standard first-line treatment.With the development of next generation sequencing,some uncommon genomic mutations have been detected.However,the effect of TKIs on such uncommon EGFR mutations remains unclear.CASE SUMMARY Here,we report a case of rare EGFR co-mutation in non-small cell lung cancer and the efficacy of afatinib on this EGFR co-mutation.A 64-year-old woman was diagnosed with thoracolumbar and bilateral local rib bone metastases,bilateral pulmonary nodules,and pericardial and left pleural effusion.The pathological diagnosis was lung adenocarcinoma.To seek potential therapeutic regimens,rare co-mutation comprising rare EGFR G724S/R776H mutations and amplification were identified.The patient experienced a significant clinical response with a progression-free survival of 17 mo.CONCLUSION A case of non-small cell lung cancer with rare EGFR G724S/R776H mutations and EGFR amplification responds well to TKI treatment. 展开更多
关键词 EGFR G724S and R776H AFATINIB Non-small cell lung cancer Case report
下载PDF
FGFR2-TSC22D1,a novel FGFR2 fusion gene identified in a patient with colorectal cancer:A case report
3
作者 Xiao-Ming Kao Xi Zhu +2 位作者 jun-ling zhang Shi-Qing Chen Chao-Gang Fan 《World Journal of Clinical Cases》 SCIE 2021年第23期6867-6871,共5页
BACKGROUND The FGFR signaling pathway is activated in multiple tumor types through gene amplifications,single base substitutions,or gene fusions.Novel FGFR gene fusions may represent candidate targets for the developm... BACKGROUND The FGFR signaling pathway is activated in multiple tumor types through gene amplifications,single base substitutions,or gene fusions.Novel FGFR gene fusions may represent candidate targets for the development of tyrosine kinase inhibitors.CASE SUMMARY Herein,we report a patient with colorectal cancer(CRC)harboring a novel FGFR2 fusion gene.A 59-year-old man felt discomfort in his right upper abdomen with loss of appetite for 6 mo.An abdominal computed tomography scan revealed the existence of a space-occupying lesion in the ascending colon.The pathological diagnosis was a poorly differentiated adenocarcinoma.Subsequent biopsy specimen was subjected to next-generation sequencing analysis,and a novel FGFR2-TSC22D1 fusion with complete kinase structure of FGFR2 protein was identified.CONCLUSION We report the first case of CRC harboring FGFR2-TSC22D1,which enriches the FGFR2 fusion spectrum.FGFR2 inhibitors might be effective in the later treatment for this patient. 展开更多
关键词 FGFR2-TSC22D1 Colorectal cancer Next-generation sequencing Case report
下载PDF
Sensor/Actuator Faults Detection for Networked Control Systems via Predictive Control 被引量:3
4
作者 Yu-Yan zhang jun-ling zhang +1 位作者 Xiao-Yuan Luo Xin-Ping Guan 《International Journal of Automation and computing》 EI CSCD 2013年第3期173-180,共8页
Quantized fault detection for sensor/actuator faults of networked control systems (NCSs) with time delays both in the sensor-to-controller channel and controller-to-actuator channel is concerned in this paper. A fau... Quantized fault detection for sensor/actuator faults of networked control systems (NCSs) with time delays both in the sensor-to-controller channel and controller-to-actuator channel is concerned in this paper. A fault model is set up based on the possible cases of sensor/atuator faults. Then, the model predictive control is used to compensate the time delay. When the sensors and actuators are healthy, an H stability criterion of the state predictive observer is obtained in terms of linear matrix inequality. A new threshold computational method that conforms to the actual situation is proposed. Then, the thresholds of the false alarm rate (FAR) and miss detection rate (MDR) are presented by using our proposed method, which are also compared with the ones given in the existin~ literatures. Finally, some numerical simulations are shown to demonstrate the effectiveness of the proposed method. 展开更多
关键词 Networked control system fault detection false alarm rate (FAR) miss detection rate (MDR) predictive control.
原文传递
Consensus on the Diagnosis and Treatment of Vitiligo in China(2021 Revision)# 被引量:4
5
作者 Tie-Chi Lei Ai-E Xu +13 位作者 Tian-Wen Gao Li He Hua Gu Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Chai-Xia Tu Hai Wen Ji-Yuan Wu jun-ling zhang Zhi-Zhong Zhen The Vitiligo Expert Group of the Dermatovenereology Professional Committee,Chinese Society of Integrated Chinese and Western Medicine 《International Journal of Dermatology and Venereology》 2021年第1期10-15,共6页
Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients.The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on ... Vitiligo is a common depigmented skin disease that negatively affects the physical and mental health of patients.The 2018 version of the Vitiligo Treatment Consensus has been updated based on the research progress on vitiligo in the past 3 years in combination with the clinical experiences of experts.The newly revised points include maintenance therapy,early glucocorticoid intervention,and oral mini-pulsed glucocorticoid administration protocols.The prospect of using JAK inhibitors in the treatment of vitiligo is also discussed. 展开更多
关键词 VITILIGO therapy GLUCOCORTICOIDS PHOTOTHERAPY calcineurin inhibitor expert consensus
原文传递
Consensus on the Diagnosis and Treatment of Melasma in China (2021 Version) 被引量:2
6
作者 Pigmentary Disorder Group,Combination of Traditional and Western Medicine Dermatology Research Center for Vitiligo,Chinese Society of Dermatology +15 位作者 Working Group on Pigmentary Disorders,China Dermatologist Association Tian-Wen Gao Hua Gu Li He Tie-Chi Lei Ming Li Tie-Nan Li Chun-Ying Li Tong Lin Kuan-Hou Mu Cai-Xia Tu Hai Wen Ji-Yuan Wu Ai-E Xu jun-ling zhang Zhi-Zhong Zhen 《International Journal of Dermatology and Venereology》 2021年第3期133-139,共7页
The pathogenesis of melasma is believed to be related to heredity,sun exposure,sex hormones,and other factors.The mechanisms underlying the development of melasma include increased melanin synthesis,vascular prolifera... The pathogenesis of melasma is believed to be related to heredity,sun exposure,sex hormones,and other factors.The mechanisms underlying the development of melasma include increased melanin synthesis,vascular proliferation within the skin lesions,inflammation,and skin barrier dysfunction.The diagnosis of melasma is mainly based on clinical manifestations and noninvasive techniques.Coupling with recent research progress in melasma,the present consensus comprehensively elaborates the etiology,pathogenesis,clinical manifestations,staging,classification,diagnosis,and treatment of melasma to improve the diagnostic and therapeutic skills of Chinese dermatologists. 展开更多
关键词 DIAGNOSIS expert consensus MELASMA THERAPY
原文传递
Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China(2020)#
7
作者 Xu Yao Zhi-Qiang Song +55 位作者 Wei Li Yun-Sheng Liang Yan Zhao Hua Cao Tao Chen Xue Chen Ai-Ping Feng Song-Mei Geng Heng Gu Shu-Ping Guo Yan-Ling He Ye-Hong Kuang Chun-Ying Li Xiao-Hong Li Zheng-Xiao Li Jun-Qin Liang Hong-Ye Liu Ling-Ling Liu Yu-Mei Liu Zhi Liu Hai Long Qian-Jin Lu Yan Lu Xiao-Qun Luo Xiao-Yan Lv Lin Ma Zhu Shen Xin Shi Zhong-Xiang Shi Xiang-Yang Su Qing Sun Jian-Ping Tang Ao-Xue Wang Hui-Ping Wang Jian-Qin Wang Ming-Yue Wang Zai-Xing Wang Yu-Min Xia Ting Xiao Zhi-Qiang Xie Huan Xing Ying Xiong Zi-Gang Xu Bin Yang Zhi-Rong Yao Jian-Bin Yu Nan Yu Kang Zeng Jian-Zhong zhang jun-ling zhang Hua Zhao Zuo-Tao Zhao Wei Zhu Ying-Hua Zhu Ying Zou Atopic Dermatitis Working Group,Immunology Group,Chinese Society of Dermatology 《International Journal of Dermatology and Venereology》 2021年第1期1-9,共9页
Atopic dermatitis(AD)is a common disease clinically characterized by chronic recurrent eczematous lesions,dry skin,and pruritus.AD can negatively impact patients’quality of life.The prevalence of AD in China has been... Atopic dermatitis(AD)is a common disease clinically characterized by chronic recurrent eczematous lesions,dry skin,and pruritus.AD can negatively impact patients’quality of life.The prevalence of AD in China has been increasing during the past few decades.Based on the most recent advances in the treatment of AD,we updated the 2014 version of the Guidelines for Diagnosis and Treatment of Atopic Dermatitis in China regarding the definition,epidemiology,pathogenesis,clinical classification,diagnosis,prevention,and treatment of AD. 展开更多
关键词 atopic dermatitis DIAGNOSIS THERAPY GUIDELINE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部